Market Place
Sourcing Support
Artelo Biosciences Presents Non-Opioid Osteoarthritis Data
13 Nov 2024 //
GLOBENEWSWIRE
Artelo Biosciences` ART26.12 Accepted into NIH Screening Program
05 Nov 2024 //
GLOBENEWSWIRE
Artelo Bio CEO to Participate in Fireside Chat On October 16th
09 Oct 2024 //
GLOBENEWSWIRE
Artelo To Present At H.C. Wainwright Investment Conference
04 Sep 2024 //
GLOBENEWSWIRE
Artelo Biosciences Reports Q2 2024 Results And Business Update
13 Aug 2024 //
GLOBENEWSWIRE
Artelo`s ART26.12 IND Application Cleared By FDA
15 Jul 2024 //
GLOBENEWSWIRE
Artelo Biosciences Presents ART12.11 Preclinical Data At ICRS Symposium
03 Jul 2024 //
GLOBENEWSWIRE
Artelo Biosciences Announces Data Supporting FABP Inhibitor Platform
02 Jul 2024 //
GLOBENEWSWIRE
Artelo Presents ART26.12 Data For Cancer-Induced Bone Pain
01 Jul 2024 //
GLOBENEWSWIRE
Artelo Bio: New ART26.12 Data At British Pain Society Meeting
04 Jun 2024 //
GLOBENEWSWIRE
Artelo`s ART12.11 Solid Dosage Form Data Encouraging At CT-CANN24
29 May 2024 //
GLOBENEWSWIRE
Artelo Biosciences Reports Q1 2024 Results, Business Update
13 May 2024 //
GLOBENEWSWIRE
Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
10 May 2024 //
GLOBENEWSWIRE
Artelo Highlights FABP7 As Cancer Therapy Target
23 Apr 2024 //
GLOBENEWSWIRE
Artelo CEO On Benzinga April 23 At 10:50AM ET
22 Apr 2024 //
GLOBENEWSWIRE
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results
25 Mar 2024 //
GLOBENEWSWIRE
Artelo Bio Selected as a Finalist in Johnson & Johnson™s Innovation Challenge
12 Mar 2024 //
GLOBENEWSWIRE
Artelo Announces Publication of Research Demonstrating ART26.12s Effectiveness
23 Jan 2024 //
GLOBENEWSWIRE
Artelo Biosciences Announces Selection of Trials to Support ART26.12
08 Jan 2024 //
GLOBENEWSWIRE
Artelo Biosciences Presents New Preclinical Data on ART12.11
05 Dec 2023 //
GLOBENEWSWIRE
Artelo Biosciences to Present Important New Preclinical Data on ART12.11
30 Nov 2023 //
GLOBENEWSWIRE
Artelo Biosciences Reports Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Artelo Announces Publication of Research Demonstrating Properties of ART27.13
09 Nov 2023 //
GLOBENEWSWIRE
Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12
02 Nov 2023 //
GLOBENEWSWIRE
Principal Investigator of Artelo`s Trial to Participate in Medical Webinar
04 Oct 2023 //
GLOBENEWSWIRE
Artelo Bio to Present at the 13th Congress of the European Pain Federation
13 Sep 2023 //
GLOBENEWSWIRE
Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12
07 Sep 2023 //
GLOBENEWSWIRE
Artelo to Present at 6th Cannabinoid-Derived Drug Development Summit
06 Sep 2023 //
GLOBENEWSWIRE
Artelo to Present at H.C. Wainwright 25th Annual Global Investment Conference
05 Sep 2023 //
GLOBENEWSWIRE
Artelo Biosciences Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Artelo Biosciences to Present New Mechanism of Action Data on ART26.12
19 Jul 2023 //
GLOBENEWSWIRE
Artelo Bio CEO to Participate in the Benzinga All Access Event on July 11
10 Jul 2023 //
GLOBENEWSWIRE
Artelo Announces Sponsorship of The William A. Devane Early Career Invstig Award
28 Jun 2023 //
GLOBENEWSWIRE
Artelo Announces Important New Data on ART26.12 Demonstrating +ve Effects
27 Jun 2023 //
GLOBENEWSWIRE
Artelo Reports Superior Pharmaceutical Properties and Efficacy of ART12.11
26 Jun 2023 //
GLOBENEWSWIRE
Artelo Selected for Presentation to Report Research Findings on ART12.11
07 Jun 2023 //
GLOBENEWSWIRE
Artelo Biosciences Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Artelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial E
25 Apr 2023 //
GLOBENEWSWIRE
Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results
31 Mar 2023 //
GLOBENEWSWIRE
Artelo Completes Enrollment of Phase 1b Stage of CAReS Trial Evaluating ART27.13
02 Feb 2023 //
GLOBENEWSWIRE
Artelo to Present at Sequire Biotechnology Conference on February 2nd
26 Jan 2023 //
GLOBENEWSWIRE
Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare
22 Sep 2022 //
GLOBENEWSWIRE
Artelo Biosciences to Present at the H.C. Wainwright 24th Annual GIC
07 Sep 2022 //
GLOBENEWSWIRE
Artelo Reports Positive Pre-Clinical Results with its Novel Inhibitor
16 Aug 2022 //
GLOBENEWSWIRE
Artelo Biosciences Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
Artelo Bio Completes Enrollment of First 3 Cohorts in CAReS Study of ART27.13
19 Jul 2022 //
GLOBENEWSWIRE
Artelo Bio Presents Positive PC Results of ART26.12 in Chemotherapy-Induced Pain
27 Jun 2022 //
GLOBENEWSWIRE
Artelo Bio Selected for Oral Presentation at 32nd Annual ICRS Symposium
24 Jun 2022 //
GLOBENEWSWIRE
Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th
01 Jun 2022 //
GLOBENEWSWIRE
Artelo Biosciences to Present at the H.C. Wainwright Conference
16 May 2022 //
GLOBENEWSWIRE
Artelo Biosciences Reports First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Artelo Bio Reports Positive Results for Lead Program in Cancer-Related Cachexia
13 Apr 2022 //
GLOBENEWSWIRE
Artelo Expands Collaboration with Trinity College Dublin in Cellular Biology
28 Mar 2022 //
GLOBENEWSWIRE
Artelo Bio to Participate in the 2022 Virtual Growth Conference by Maxim Group
22 Mar 2022 //
GLOBENEWSWIRE
Artelo Bio Reports Four-Month 2021 Financial Results; Provides Business Update
21 Mar 2022 //
GLOBENEWSWIRE
Artelo Bags Notice of Allowance for Method-of-Use Patent in U.S. for ART12.11
02 Mar 2022 //
GLOBENEWSWIRE
Artelo Biosciences Reports Q1 Fiscal Year 2022 Financial Results
12 Jan 2022 //
GLOBENEWSWIRE
Artelo Anticipates Accelerated Clinical Development for ART27.13
11 Jan 2022 //
GLOBENEWSWIRE
Artelo Biosciences Leadership to Participate on Endocannabinoid Panel
10 Jan 2022 //
GLOBENEWSWIRE
Ladenburg R&D Showcase Featuring Artelo CAReS Study on July 28, 2021
21 Jul 2021 //
GLOBENEWSWIRE
